DRUG-THERAPY - CANDIDATE AIDS VACCINES

被引：98

作者：

GRAHAM, BS

WRIGHT, PF

机构：

[1] VANDERBILT UNIV, SCH MED, DEPT PEDIAT, NASHVILLE, TN 37232 USA

[2] VANDERBILT UNIV, SCH MED, DEPT MICROBIOL & IMMUNOL, NASHVILLE, TN 37232 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1995年 / 333卷 / 20期

关键词：

D O I：

10.1056/NEJM199511163332007

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

There is an urgent need to control the global epidemic of human immunodeficiency virus type 1 (HIV-1) infection. Although educational approaches to modify risk-taking behavior are a critical component of prevention, we focus this discussion on the status of vaccine development. The success of active immunization against other infectious diseases makes immunization an attractive approach to preventing HIV-1 infection. The eradication of smallpox1 and progress in the elimination of poliomyelitis, targeted to occur by the year 2000,2 are notable examples of the impact of vaccination. Given the complexity of HIV-1 pathogenesis, however, empirical approaches successful in the development of previous. © 1995, Massachusetts Medical Society. All rights reserved.

引用

收藏

页码：1331 / 1339

页数：9

相关论文

共 102 条

[11]

BURKE DS, 1992, PERSPECT BIOL MED, V35, P511

[12] BIOLOGY OF CLONED CYTO-TOXIC LYMPHOCYTES-T SPECIFIC FOR LYMPHOCYTIC CHORIOMENINGITIS VIRUS - CLEARANCE OF VIRUS INVIVO [J].

BYRNE, JA ;

OLDSTONE, MBA .

JOURNAL OF VIROLOGY, 1984, 51 (03) :682-686

[13] DEVELOPMENT OF A QUASI-SPECIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INVIVO [J].

CICHUTEK, K ;

MERGET, H ;

NORLEY, S ;

LINDE, R ;

KREUZ, W ;

GAHR, M ;

KURTH, R .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) :7365-7369

[14] ENHANCED IMMUNITY TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ENVELOPE ELICITED BY A COMBINED VACCINE REGIMEN CONSISTING OF PRIMING WITH A VACCINIA RECOMBINANT EXPRESSING HIV ENVELOPE AND BOOSTING WITH GP160-PROTEIN [J].

COONEY, EL ;

MCELRATH, MJ ;

COREY, L ;

HU, SL ;

COLLIER, AC ;

ARDITTI, D ;

HOFFMAN, M ;

COOMBS, RW ;

SMITH, GE ;

GREENBERG, PD .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (05) :1882-1886

[15] INDUCTION OF CYTOTOXIC T-LYMPHOCYTES BY RECOMBINANT CANARYPOX (ALVAC) AND ATTENUATED VACCINIA (NYVAC) VIRUSES EXPRESSING THE HIV-1 ENVELOPE GLYCOPROTEIN [J].

COX, WI ;

TARTAGLIA, J ;

PAOLETTI, E .

VIROLOGY, 1993, 195 (02) :845-850

[16] INTRARECTAL CHALLENGE OF MACAQUES VACCINATED WITH FORMALIN-INACTIVATED SIMIAN IMMUNODEFICIENCY VIRUS [J].

CRANAGE, MP ;

BASKERVILLE, A ;

ASHWORTH, LAE ;

DENNIS, M ;

COOK, N ;

SHARPE, S ;

FARRAR, G ;

ROSE, J ;

KITCHIN, PA ;

GREENAWAY, PJ .

LANCET, 1992, 339 (8788) :273-274

[17] STUDIES ON THE SPECIFICITY OF THE VACCINE EFFECT ELICITED BY INACTIVATED SIMIAN IMMUNODEFICIENCY VIRUS [J].

CRANAGE, MP ;

POLYANSKAYA, N ;

MCBRIDE, B ;

COOK, N ;

ASHWORTH, LAE ;

DENNIS, M ;

BASKERVILLE, A ;

GREENAWAY, PJ ;

CORCORAN, T ;

KITCHIN, P ;

ROSE, J ;

MURPHEYCORB, M ;

DESROSIERS, RC ;

STOTT, EJ ;

FARRAR, GH .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (01) :13-22

[18] PROTECTIVE EFFECTS OF A LIVE ATTENUATED SIV VACCINE WITH A DELETION IN THE NEF GENE [J].

DANIEL, MD ;

KIRCHHOFF, F ;

CZAJAK, SC ;

SEHGAL, PK ;

DESROSIERS, RC .

SCIENCE, 1992, 258 (5090) :1938-1941

[19] MACROMOLECULAR ASSEMBLAGE IN THE DESIGN OF A SYNTHETIC AIDS VACCINE [J].

DEFOORT, JP ;

NARDELLI, B ;

HUANG, WL ;

HO, DD ;

TAM, JP .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) :3879-3883

[20] INVIVO PRIMING OF VIRUS-SPECIFIC CYTO-TOXIC LYMPHOCYTES-T WITH SYNTHETIC LIPOPEPTIDE VACCINE [J].

DERES, K ;

SCHILD, H ;

WIESMULLER, KH ;

JUNG, G ;

RAMMENSEE, HG .

NATURE, 1989, 342 (6249) :561-564

← 1 2 3 4 5 6 7 8 9 10 →